FDA Establishment Registration and Device Listing: Who Must Register?
FDA REGISTRATION REQUIREMENTS
FDA establishment registration and device listing are determined primarily by what each establishment does—not simply by which company owns the product, holds the marketing authorization, or appears on the commercial invoice.
FDA establishment registration and device listing are determined primarily by what each establishment does—not simply by which company owns the product, holds the marketing authorization, or appears on the commercial invoice.
Registration Follows the Establishment’s Regulatory Role
FDA generally requires establishments involved in producing or processing devices for U.S. commercial distribution to register annually. Registrable roles include finished-device manufacturers, specification developers, contract manufacturers and packagers, contract sterilizers, repackagers, relabelers, remanufacturers, and certain other establishments performing regulated activities.
A specification developer may have no factory and never physically handle inventory yet still require registration because it develops or controls the specifications under which another party manufactures the device. Contract manufacturers and sterilizers of finished devices generally must register and list even when they return the product to their customer rather than placing it directly into commercial distribution.
Foreign Manufacturing Usually Involves Multiple Registrations
A common misconception is that a foreign-manufactured device requires only one FDA registration. Registration attaches to each registrable establishment and role, not to the product as a single commercial project.
Product Ownership Is Relevant—but Not Decisive
For example, where a U.S. device company develops the specifications and engages a factory overseas, the U.S. company may need to register and list as the specification developer, while the foreign factory must separately register and list as the contract manufacturer. Each registrable establishment ordinarily maintains its own registration and pays its own annual establishment registration fee.
Additional registrations may also be required. A foreign contract sterilizer, repackager, or relabeler may have its own registration and listing obligations. The U.S. initial importer must separately register and identify the foreign manufacturers whose devices it imports, although an initial importer acting only in that capacity generally does not create the manufacturer’s device listing.
A foreign establishment must also designate a U.S. agent, but the U.S. agent designation is part of the foreign establishment’s registration. It does not replace the registration of a U.S. specification developer, initial importer, or other registrable U.S. establishment.
The U.S. and foreign registrations are therefore coordinated, but they are not interchangeable. FDA’s listing sequence may require the manufacturer or specification developer to list the device before a foreign contract manufacturer or contract sterilizer can associate its activities with that device. One company’s registration does not “cover” the other entities or facilities in the manufacturing and import chain.
Ownership of the 510(k), De Novo authorization, PMA, design, trademark, or inventory may help identify the responsible parties, but the decisive questions concern who controls the specifications and labeling, who performs manufacturing or processing activities, who imports the product, and how each establishment participates in U.S. commercial distribution.
Build a Coordinated Registration Structure
A domestic distributor that merely purchases and resells finished devices without importing, manufacturing, repackaging, relabeling, or processing them generally does not register solely because it owns inventory.
MDD Options’ hybrid model can provide the U.S. commercial infrastructure needed to support a foreign manufacturer, including Initial Importer activities, establishment-registration and device-listing administration, import coordination, and downstream distribution. This allows the manufacturer to build a coordinated registration structure across its foreign facilities, U.S. regulatory entities, and commercial channels without incorrectly treating FDA registration as a single-company filing.